scholarly article | Q13442814 |
P2093 | author name string | Terry K Bertin | |
Brendan Lee | |||
Susana Mouriño | |||
Masataka Suzuki | |||
Racel Cela | |||
Christian Clarke | |||
P2860 | cites work | Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. | Q33337331 |
A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia | Q33348516 | ||
Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A | Q33356962 | ||
A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal | Q35915922 | ||
Helper-dependent adenoviral vectors for gene therapy | Q36036219 | ||
Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons | Q36557727 | ||
Methods for the production of helper-dependent adenoviral vectors | Q39954011 | ||
Physical and infectious titers of helper-dependent adenoviral vectors: a method of direct comparison to the adenovirus reference material | Q40510393 | ||
Improved system for helper-dependent adenoviral vector production | Q40619668 | ||
Optimization of the generation and propagation of gutless adenoviral vectors | Q40663790 | ||
Construction of first-generation adenoviral vectors. | Q40734635 | ||
Preparation of helper-dependent adenoviral vectors | Q40734638 | ||
Development of a FLP/frt system for generating helper-dependent adenoviral vectors | Q40805792 | ||
A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector | Q40810172 | ||
Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. | Q44765402 | ||
Correction of murine hemophilia A and immunological differences of factor VIII variants delivered by helper-dependent adenoviral vectors | Q45870948 | ||
Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages | Q45877053 | ||
Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses | Q64378497 | ||
P433 | issue | 1 | |
P921 | main subject | Adenoviridae | Q193447 |
P304 | page(s) | 120-126 | |
P577 | publication date | 2010-01-01 | |
P1433 | published in | Human Gene Therapy | Q15757580 |
P1476 | title | Large-scale production of high-quality helper-dependent adenoviral vectors using adherent cells in cell factories | |
P478 | volume | 21 |
Q33877450 | A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeutics |
Q41925180 | Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer |
Q38714964 | Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors |
Q41429339 | Canine helper-dependent vectors production: implications of Cre activity and co-infection on adenovirus propagation. |
Q42424335 | Capsid-modified adenoviral vectors for improved muscle-directed gene therapy |
Q36664224 | Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy |
Q36740271 | Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo |
Q36444154 | Enhancing Autophagy with Drugs or Lung-directed Gene Therapy Reverses the Pathological Effects of Respiratory Epithelial Cell Proteinopathy. |
Q51847569 | Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy. |
Q38302375 | Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1. |
Q34993431 | Helper-dependent adenovirus is superior to first-generation adenovirus for expressing transgenes in atherosclerosis-prone arteries |
Q38945731 | Impact of adenovirus life cycle progression on the generation of canine helper-dependent vectors. |
Q35226121 | NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo. |
Q90974934 | No more helper adenovirus: production of gutless adenovirus (GLAd) free of adenovirus and replication-competent adenovirus (RCA) contaminants |
Q90127107 | Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors |
Q38719412 | Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis |
Q34619757 | Proteoglycan 4 expression protects against the development of osteoarthritis |
Q36678182 | Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice |
Q36740254 | SR-A and SREC-I are Kupffer and endothelial cell receptors for helper-dependent adenoviral vectors |
Q35224065 | SR-A and SREC-I binding peptides increase HDAd-mediated liver transduction. |
Q45367025 | Self-inactivating helper virus for the production of high-capacity adenoviral vectors |
Q39534390 | Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration. |
Q37225109 | Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes |